C. R. Hansen, “Eliminating the high-risk CTV1 margin in DAHANCA oropharyngeal radiotherapy: Dosimetric impact on dysphagia and organ-at-risk doses”, AO, vol. 64, pp. 1205–1211, Sep. 2025.